BACKGROUND: No study has assessed the cost of treating adult Medicaid cancer patients with preexisting chronic conditions. This information is essential for understanding the cost of cancer care to the Medicaid program above that expended for other chronic conditions, given the increasing prevalence of chronic conditions among cancer patients. RESEARCH DESIGN: We used administrative data from 3 state Medicaid programs' linked cancer registry data to estimate cost of care during the first 6 months following cancer diagnosis for beneficiaries with 4 preexisting chronic conditions: cardiac disease, respiratory diseases, diabetes, and mental health disorders. Our base cohort consisted of 6,212 Medicaid cancer patients aged 21 to 64 years (cancer diagnosed during 2001-2003) who were continuously enrolled in fee-for-service Medicaid for 6 months after diagnosis. A subset of these patients who did not die during the 6-month follow-up (n=4,628), were matched with 2 non-cancer patients each (n=8,536) to assess incremental cost of care. RESULTS: The average cost of care for cancer patients with the chronic conditions studied was higher than for cancer patients without any of these conditions. The increase in cancer treatment cost associated with the chronic conditions ranged from $4,385 for cardiac disease to $11,009 for mental health disorders. CONCLUSIONS: Chronic conditions, especially the presence of multiple conditions, are associated with a higher cost of care among Medicaid cancer patients, and these increased costs should be reflected in projections of future Medicaid cancer care costs. The implementation of better care-management processes for cancer patients with preexisting chronic conditions may be one way to reduce these costs.
BACKGROUND: No study has assessed the cost of treating adult Medicaid cancerpatients with preexisting chronic conditions. This information is essential for understanding the cost of cancer care to the Medicaid program above that expended for other chronic conditions, given the increasing prevalence of chronic conditions among cancerpatients. RESEARCH DESIGN: We used administrative data from 3 state Medicaid programs' linked cancer registry data to estimate cost of care during the first 6 months following cancer diagnosis for beneficiaries with 4 preexisting chronic conditions: cardiac disease, respiratory diseases, diabetes, and mental health disorders. Our base cohort consisted of 6,212 Medicaid cancerpatients aged 21 to 64 years (cancer diagnosed during 2001-2003) who were continuously enrolled in fee-for-service Medicaid for 6 months after diagnosis. A subset of these patients who did not die during the 6-month follow-up (n=4,628), were matched with 2 non-cancerpatients each (n=8,536) to assess incremental cost of care. RESULTS: The average cost of care for cancerpatients with the chronic conditions studied was higher than for cancerpatients without any of these conditions. The increase in cancer treatment cost associated with the chronic conditions ranged from $4,385 for cardiac disease to $11,009 for mental health disorders. CONCLUSIONS: Chronic conditions, especially the presence of multiple conditions, are associated with a higher cost of care among Medicaid cancerpatients, and these increased costs should be reflected in projections of future Medicaid cancer care costs. The implementation of better care-management processes for cancerpatients with preexisting chronic conditions may be one way to reduce these costs.
Authors: G T Ray; F Collin; T Lieu; B Fireman; C J Colby; C P Quesenberry; S K Van den Eeden; J V Selby Journal: Med Care Res Rev Date: 2000-03 Impact factor: 3.929
Authors: Thomas T A Peters; Bernard F A M van der Laan; Boudewijn E C Plaat; Jan Wedman; Johannes A Langendijk; Gyorgy B Halmos Journal: Oral Oncol Date: 2010-12-15 Impact factor: 5.337
Authors: Vincent L Freeman; Ana C Ricardo; Richard T Campbell; Richard E Barrett; Richard B Warnecke Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-07-22 Impact factor: 4.254
Authors: Joan L Warren; Martin L Brown; Michael P Fay; Nicola Schussler; Arnold L Potosky; Gerald F Riley Journal: J Clin Oncol Date: 2002-01-01 Impact factor: 44.544
Authors: Gregory C Pope; John Kautter; Randall P Ellis; Arlene S Ash; John Z Ayanian; Lisa I Lezzoni; Melvin J Ingber; Jesse M Levy; John Robst Journal: Health Care Financ Rev Date: 2004
Authors: Sun Hee Rim; Gery P Guy; K Robin Yabroff; Kathleen A McGraw; Donatus U Ekwueme Journal: Expert Rev Pharmacoecon Outcomes Res Date: 2016-10-06 Impact factor: 2.217
Authors: Gery P Guy; K Robin Yabroff; Donatus U Ekwueme; Sun Hee Rim; Rui Li; Lisa C Richardson Journal: J Clin Oncol Date: 2017-05-04 Impact factor: 44.544
Authors: Chan Shen; Yiyi Chu; Daniel M Halperin; Arvind Dasari; Shouhao Zhou; Ying Xu; James C Yao; Ya-Chen Tina Shih Journal: Oncologist Date: 2017-06-22
Authors: Jaya S Khushalani; Jin Qin; John Cyrus; Natasha Buchanan Lunsford; Sun Hee Rim; Xuesong Han; K Robin Yabroff; Donatus U Ekwueme Journal: Expert Rev Pharmacoecon Outcomes Res Date: 2018-06-20 Impact factor: 2.217
Authors: Lisa P Spees; Stephanie B Wheeler; Xi Zhou; Krutika B Amin; Christopher D Baggett; Jennifer L Lund; Benjamin Y Urick; Joel F Farley; Katherine E Reeder-Hayes; Justin G Trogdon Journal: Cancer Date: 2020-08-11 Impact factor: 6.860
Authors: Tingting Wu; Fan Yang; Wendy Wing Lok Chan; Cindy Lo Kuen Lam; Carlos King Ho Wong Journal: J Diabetes Investig Date: 2020-07-16 Impact factor: 4.232